<DOC>
	<DOCNO>NCT01820130</DOCNO>
	<brief_summary>The purpose clinical investigation evaluate safety efficacy Spinal Cord Stimulation ( SCS ) advance heart failure ( HF ) patient Implantable Cardioverter Defibrillator ( ICD ) indicate Cardiac Resynchronization Therapy ( CRT ) .</brief_summary>
	<brief_title>Trial Autonomic neuroModulation trEatment Chronic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients Left Ventricular Ejection Fraction ( LVEF ) less equal 35 % Patient New York Heart Association ( NYHA ) Class III Patient QRS duration &lt; 120 m ( nonpaced QRS , time device Implant protocol inclusion ) Patient ICD implant &gt; 90 day Patient receive stable optimal medical therapy HF ( &gt; 90 day ) describe `` European Society Cardiology 2012 recommendation diagnosis treatment acute chronic Heart Failure '' , except case contraindication allergy Patient able provide write Informed Consent prior investigational related procedure Patient currently implant spinal cord stimulator previously implant spinal cord stimulator explanted previous spinal surgery would interfere implant percutaneous SCS lead upper thoracic region Patient polyneuropathy Patient require shortwave diathermy , microwave diathermy therapeutic ultrasound diathermy Patient NYHA class IV Patient receive tissue / organ transplant expect tissue / organ transplant within next 180 day Patient cardiac resynchronization therapy ( CRT ) device , LV Assist device expect receive CRT , leave ventricular assist device ( LVAD ) within next 180 day Patient critical valvular heart disease require valve repair replacement Patient myocardial infarction ( MI ) cardiac revascularization procedure ( percutaneous coronary intervention coronary artery bypass graft ) within 90 day enrollment Patient IV inotropic therapy Patient active myocarditis early postpartum cardiomyopathy Patient take follow drug within 30 day enrollment : systemic corticosteroid , cytostatic immunosuppressive drug therapy ( cyclophosphamide , methotrexate , cyclosporine , azathioprine , etc . ) , DNA deplete cytotoxic drug Patient pregnant , childbearing potential use adequate contraceptive method , nurse Patient bleeding tendency ( INR &gt; 1.2 platelet count &lt; 100 x109 per liter ) Patient local infection ICD implant location systemic infection Patient renal insufficiency ( creatinine &gt; 3.0 mg/dl ) Patient risk allergy SCS device component material Patient one follow condition must consider non relevant SCS implantation : 1 . / Patient active stent 2 . / Patient bare metal stent le 6 month 3 . / Patient present acute coronary syndrome within last 6 month 4 . / Patient stent common 5 . / Patient history stent thrombosis 6 . / Coronary Patient receive double antiplatelet medication Patient participate another clinical study active treatment arm Patient le 18 year old Patient 's life 's expectancy le 1 year assess investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>